Differences of Reasons for Alert Overrides on Contraindicated Co-prescriptions by Admitting Department

다국어 초록 (Multilingual Abstract)

Objectives: To reveal differences in drug-drug interaction (DDI) alerts and the reasons for alert overrides between admitting departments. Methods: A retrospective observational study was performed using longitudinal Electronic Health Record (EHR) data and information from an alert and logging system. Adult patients hospitalized in the emergency department (ED) and general ward (GW) during a 46-month period were included. For qualitative analyses, we manually reviewed all reasons for alert overrides, which were recorded as free text in the EHRs. Results: Among 14,780,519 prescriptions, 51,864 had alerts for DDIs (0.35%; 1.32% in the ED and 0.23% in the GW). The alert override rate was higher in the ED (94.0%) than in the GW (57.0%) (p < 0.001). In an analysis of the study population, including ED and GW patients, ‘clinically irrelevant alert’ (52.0%) was the most common reason for override, followed by ‘benefit assessed to be greater than the risk’ (31.1%) and ‘others’ (17.3%). The frequency of alert overrides was highest for anti-inflammatory and anti-rheumatic drugs (89%). In a sub-analysis of the population, ‘clinically irrelevant alert’ was the most common reason for alert overrides in the ED (69.3%), and ‘benefit assessed to be greater than the risk’ was the most common reason in the GW (61.4%). Conclusions: We confirmed that the DDI alerts and the reasons for alert overrides differed by admitting department. Different strategies may be efficient for each admitting department.

참고문헌 (Reference)

1 Seidling HM, "What, if all alerts were specific - estimating the potential impact on drug interaction alert burden" 83 (83): 285-291, 2014

2 van der Sijs H, "Turning off frequently overridden drug alerts: limited opportunities for doing it safely" 15 (15): 439-448, 2008

3 van der Sijs H, "Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication error reductions" 16 (16): 864-868, 2009

4 Bottiger Y, "SFINX-a drug-drug interaction database designed for clinical decision support systems" 65 (65): 627-633, 2009

5 Grizzle AJ, "Reasons provided by prescribers when overriding drug-drug interaction alerts" 13 (13): 573-578, 2007

6 Taylor LK, "Reasons for physician nonadherence to electronic drug alerts" 107 (107): 1101-1105, 2004

7 Cruciol-Souza JM, "Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital" 9 (9): 427-433, 2006

8 Vonbach P, "Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine" 19 (19): 413-420, 2008

9 Fokter N, "Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments" 122 (122): 81-88, 2010

10 Weingart SN, "Physicians' decisions to override computerized drug alerts in primary care" 163 (163): 2625-2631, 2003

11 Mantyselka P, "Pain as a reason to visit the doctor: a study in Finnish primary health care" 89 (89): 175-180, 2001

12 van der Sijs H, "Overriding of drug safety alerts in computerized physician order entry" 13 (13): 138-147, 2006

13 Rosenberg SN, "Overrides of medication alerts in ambulatory care" 169 (169): 1337-, 2009

14 Isaac T, "Overrides of medication alerts in ambulatory care" 169 (169): 305-311, 2009

15 Glassman PA, "Improving recognition of drug interactions: benefits and barriers to using automated drug alerts" 40 (40): 1161-1171, 2002

16 Shah NR, "Improving acceptance of computerized prescribing alerts in ambulatory care" 13 (13): 5-11, 2006

17 Becker ML, "Hospitalisations and emergency department visits due to drug-drug interactions:a literature review" 16 (16): 641-651, 2007

18 Smithburger PL, "Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings" 44 (44): 1718-1724, 2010

19 Ahearn MD, "General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software" 179 (179): 34-37, 2003

20 Magnus D, "GPs' views on computerized drug interaction alerts: questionnaire survey" 27 (27): 377-382, 2002

21 Hamilton RA, "Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population" 18 (18): 1112-1120, 1998

22 Zwart-van Rijkom JE, "Frequency and nature of drug-drug interactions in a Dutch university hospital" 68 (68): 187-193, 2009

23 Seidling HM, "Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support" 18 (18): 479-484, 2011

24 Jankel CA, "Epidemiology of drug-drug interactions as a cause of hospital admissions" 9 (9): 51-59, 1993

25 Pasina L, "Drug-drug interactions in a cohort of hospitalized elderly patients" 22 (22): 1054-1060, 2013

26 van der Sijs H, "Drug safety alert generation and overriding in a large Dutch university medical centre" 18 (18): 941-947, 2009

27 Tatro DS, "Drug interaction fact" Facts and Comparisons 1992

28 Ahn EK, "Differences among admitting departments in alerts and alert overrides for drug-drug interaction" 23 (23): 390-397, 2014

29 Teich JM, "CDS Expert Review Panel. Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup" 12 (12): 365-376, 2005

30 Mille F, "Analysis of overridden alerts in a drug-drug interaction detection system" 20 (20): 400-405, 2008

31 Korea Ministry of Food and Drug Safety, "Act for ingredient of contraindicated co-prescriptions of medicine" Ministry of Food and Drug Safety

32 Tamblyn R, "A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care" 15 (15): 430-438, 2008

33 Smithburger PL, "A critical evaluation of clinical decision support for the detection of drug-drug interactions" 10 (10): 871-882, 2011